ReP USP - Resultado da busca

Artigo de periodico
Purinergic system in cancer stem cells (2025)
Rios, J. D. Nuñez; Ulrich, Henning ; Muñoz, M. Díaz; Lameu, Claudiana ; Cuevas, F. G. Vázquez
Source: Purinergic Signalling. Unidade: IQ
Subjects: CÉLULAS-TRONCO, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIOS, J. D. Nuñez et al. Purinergic system in cancer stem cells. Purinergic Signalling, v. 21, p. 23-38, 2025Tradução . . Disponível em: https://dx.doi.org/10.1007/s11302-023-09976-5. Acesso em: 08 out. 2025.
APA
Rios, J. D. N., Ulrich, H., Muñoz, M. D., Lameu, C., & Cuevas, F. G. V. (2025). Purinergic system in cancer stem cells. Purinergic Signalling, 21, 23-38. doi:10.1007/s11302-023-09976-5
NLM
Rios JDN, Ulrich H, Muñoz MD, Lameu C, Cuevas FGV. Purinergic system in cancer stem cells [Internet]. Purinergic Signalling. 2025 ; 21 23-38.[citado 2025 out. 08 ] Available from: https://dx.doi.org/10.1007/s11302-023-09976-5
Vancouver
Rios JDN, Ulrich H, Muñoz MD, Lameu C, Cuevas FGV. Purinergic system in cancer stem cells [Internet]. Purinergic Signalling. 2025 ; 21 23-38.[citado 2025 out. 08 ] Available from: https://dx.doi.org/10.1007/s11302-023-09976-5
Artigo de periodico
Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies (2023)
Jia, Wenhui; Huang, Zhao; Zhou, Li; Liou, Yih-Cherng; Virgilio, Francesco Di ; Ulrich, Henning ; Peter, Illes; Zhang, Wei; Huang, Canhua ; Tang, Yong
Source: Drug Resistance Updates. Unidade: IQ
Subjects: NEOPLASIAS, PURINAS, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JIA, Wenhui et al. Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies. Drug Resistance Updates, v. 70, p. 1-13 art. 100988, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.drup.2023.100988. Acesso em: 08 out. 2025.
APA
Jia, W., Huang, Z., Zhou, L., Liou, Y. -C., Virgilio, F. D., Ulrich, H., et al. (2023). Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies. Drug Resistance Updates, 70, 1-13 art. 100988. doi:10.1016/j.drup.2023.100988
NLM
Jia W, Huang Z, Zhou L, Liou Y-C, Virgilio FD, Ulrich H, Peter I, Zhang W, Huang C, Tang Y. Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies [Internet]. Drug Resistance Updates. 2023 ; 70 1-13 art. 100988.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.drup.2023.100988
Vancouver
Jia W, Huang Z, Zhou L, Liou Y-C, Virgilio FD, Ulrich H, Peter I, Zhang W, Huang C, Tang Y. Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies [Internet]. Drug Resistance Updates. 2023 ; 70 1-13 art. 100988.[citado 2025 out. 08 ] Available from: https://doi.org/10.1016/j.drup.2023.100988
Artigo de periodico
Epothilones as natural compounds for novel anticancer drugs development (2023)
Villegas, Cecilia ; Chavarría, Iván González ; Burgos, Viviana; Beiza, Héctor Iturra; Ulrich, Henning ; Paz, Cristian
Source: International Journal of Molecular Sciences. Unidade: IQ
Subjects: NEOPLASIAS, NEOPLASIAS MAMÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VILLEGAS, Cecilia et al. Epothilones as natural compounds for novel anticancer drugs development. International Journal of Molecular Sciences, v. 24, p. 1-20 art. 6063, 2023Tradução . . Disponível em: https://doi.org/10.3390/ijms24076063. Acesso em: 08 out. 2025.
APA
Villegas, C., Chavarría, I. G., Burgos, V., Beiza, H. I., Ulrich, H., & Paz, C. (2023). Epothilones as natural compounds for novel anticancer drugs development. International Journal of Molecular Sciences, 24, 1-20 art. 6063. doi:10.3390/ijms24076063
NLM
Villegas C, Chavarría IG, Burgos V, Beiza HI, Ulrich H, Paz C. Epothilones as natural compounds for novel anticancer drugs development [Internet]. International Journal of Molecular Sciences. 2023 ; 24 1-20 art. 6063.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/ijms24076063
Vancouver
Villegas C, Chavarría IG, Burgos V, Beiza HI, Ulrich H, Paz C. Epothilones as natural compounds for novel anticancer drugs development [Internet]. International Journal of Molecular Sciences. 2023 ; 24 1-20 art. 6063.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/ijms24076063
Artigo de periodico
Cancer metabostemness and metabolic reprogramming via P2X7 receptor (2021)
Rabelo, Izadora Lorrany Alves; Sampaio, Vanessa Fernandes Arnaud ; Adinolfi, Elena ; Ulrich, Henning ; Lameu, Claudiana
Source: Cells. Unidade: IQ
Subjects: CÉLULAS-TRONCO, NEOPLASIAS, RECEPTORES, METÁSTASE NEOPLÁSICA, METABOLISMO, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RABELO, Izadora Lorrany Alves et al. Cancer metabostemness and metabolic reprogramming via P2X7 receptor. Cells, v. 10, p. 1-15 art. 1782, 2021Tradução . . Disponível em: https://doi.org/10.3390/cells10071782. Acesso em: 08 out. 2025.
APA
Rabelo, I. L. A., Sampaio, V. F. A., Adinolfi, E., Ulrich, H., & Lameu, C. (2021). Cancer metabostemness and metabolic reprogramming via P2X7 receptor. Cells, 10, 1-15 art. 1782. doi:10.3390/cells10071782
NLM
Rabelo ILA, Sampaio VFA, Adinolfi E, Ulrich H, Lameu C. Cancer metabostemness and metabolic reprogramming via P2X7 receptor [Internet]. Cells. 2021 ; 10 1-15 art. 1782.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/cells10071782
Vancouver
Rabelo ILA, Sampaio VFA, Adinolfi E, Ulrich H, Lameu C. Cancer metabostemness and metabolic reprogramming via P2X7 receptor [Internet]. Cells. 2021 ; 10 1-15 art. 1782.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/cells10071782

USP Schools

ReP

Filtros

Authors

Subjects

Funding Agencies

Non normalized affiliation